Amarin | AMRN - Current Assets

Amarin reported $686.52M in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Assets Change
DBV Technologies DBVT:US USD 223.07M 2.62M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 1.4M
Amarin AMRN:US USD 686.52M 32.6M
AstraZeneca AZN:LN USD 22.59B 2.37B
Esperion Therapeutics ESPR:US USD 246.68M 15.1M
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Halozyme Therapeutics HALO:US USD 739.01M 85.81M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
IONIS PHARMACEUT IONS:US USD 2.2B 50.57M
JAZZ PHA JAZZ:US USD 2.61B 34.64M
Nektar Therapeutics NKTR:US USD 545.97M 53.52M
Neurocrine Biosciences NBIX:US USD 1.45B 248M
Novartis NOVN:VX USD 36.91B 44M
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M